Peramivir-Markt – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00014944
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKTEINFÜHRUNG Peramivir ist ein antivirales Medikament mit Wirkung gegen das Influenzavirus. Peramivir ist ein Neuraminidase-Inhibitor, der als analoger Übergangszustands-Inhibitor der Influenza-Neuraminidase fungiert, indem er verhindert, dass neue Viren aus infizierten Zellen entstehen. Peramivir-Injektion wird zur Behandlung bestimmter Arten von Influenza-Infektionen (Grippe) bei Erwachsenen und Kindern ab zwei Jahren angewendet, die seit nicht mehr als zwei Tagen Grippesymptome haben. MARKTDYNAMIK Die wachsende Prävalenz von Viruserkrankungen und die steigende Zahl geriatrischer Bevölkerungsgruppen sind die Hauptfaktoren, die die Nachfrage nach Peramivir antreiben. Es wird jedoch erwartet, dass die hohen Kosten und negativen Auswirkungen von Peramivir das Marktwachstum in den prognostizierten Jahren bremsen werden. Darüber hinaus wird erwartet, dass Marktteilnehmer mit fortschrittlichen Produkten aufgrund der steigenden Gesundheitsausgaben eine Chance für Marktwachstum bieten. MARKTUMFANG Die „Peramivir-Marktanalyse bis 2031“ ist eine spezialisierte und eingehende Studie der Gesundheitsbranche mit besonderem Schwerpunkt auf der globalen Markttrendanalyse. Der Bericht soll einen Überblick über den Peramivir-Markt mit detaillierter Marktsegmentierung nach Typ und Anwendung geben. Für den Peramivir-Markt wird im Prognosezeitraum ein hohes Wachstum erwartet. Der Bericht liefert wichtige Statistiken zum Marktstatus der führenden Akteure auf dem Peramivir-Markt und bietet wichtige Trends und Chancen auf dem Markt. MARKTSEGMENTIERUNG Der Peramivir-Markt ist nach Typ und Anwendung segmentiert. Je nach Typ wird der Markt in Lösung und Solid unterteilt. Basierend auf der Anwendung wird der Markt in Influenza-A-Behandlung und Influenza-B-Behandlung unterteilt. Der Bericht bietet einen detaillierten Überblick über die Branche, einschließlich qualitativer und quantitativer Informationen. Es bietet einen Überblick und eine Prognose des Peramivir-Marktes basierend auf verschiedenen Segmenten. Es bietet auch Marktgrößen- und Prognoseschätzungen für die Jahre 2021 bis 2031 in Bezug auf fünf Hauptregionen, nämlich: Nordamerika, Europa, Asien-Pazifik (APAC), Naher Osten und Afrika (MEA) sowie Süd- und Mittelamerika. Der Peramivir-Markt nach Regionen wird später nach jeweiligen Ländern und Segmenten unterteilt. Der Bericht umfasst Analysen und Prognosen für 18 Länder weltweit sowie aktuelle Trends und Chancen in der Region. Der Bericht analysiert Faktoren, die den Peramivir-Markt sowohl auf der Nachfrage- als auch auf der Angebotsseite beeinflussen, und bewertet weiter die Marktdynamik, die den Markt im Prognosezeitraum beeinflusst, d. h. Treiber, Beschränkungen, Chancen und zukünftige Trends. Der Bericht bietet außerdem eine umfassende Schädlingsanalyse für alle fünf Regionen, nämlich: Nordamerika, Europa, APAC, MEA sowie Süd- und Mittelamerika nach Bewertung politischer, wirtschaftlicher, sozialer und technologischer Faktoren, die den Peramivir-Markt in diesen Regionen beeinflussen. MARKTSPIELER Der Bericht behandelt wichtige Entwicklungen auf dem Peramivir-Markt als organische und anorganische Wachstumsstrategien. Verschiedene Unternehmen konzentrieren sich auf organische Wachstumsstrategien wie Produkteinführungen, Produktzulassungen und andere wie Patente und Veranstaltungen. Zu den auf dem Markt beobachteten anorganischen Wachstumsstrategien gehörten Akquisitionen sowie Partnerschaften und Kooperationen. Diese Aktivitäten haben den Weg für die Erweiterung des Geschäfts und des Kundenstamms der Marktteilnehmer geebnet. Aufgrund der steigenden Nachfrage nach Peramivir auf dem Weltmarkt werden den Marktteilnehmern auf dem Peramivir-Markt in Zukunft voraussichtlich lukrative Wachstumschancen geboten. Nachfolgend finden Sie eine Liste einiger Unternehmen, die auf dem Peramivir-Markt tätig sind. Der Bericht enthält auch die Profile der wichtigsten Akteure auf dem Peramivir-Markt sowie deren SWOT-Analyse und Marktstrategien. Darüber hinaus konzentriert sich der Bericht auf führende Branchenakteure mit Informationen wie Firmenprofilen, angebotenen Komponenten und Dienstleistungen, Finanzinformationen der letzten drei Jahre und wichtigen Entwicklungen in den letzten fünf Jahren.
    •  Green Cross Pharma •  Shionogi Co. •  Neopharm •  Moksha8 Pharma •  NT Pharma •  Merck •  Hikma Pharmaceuticals •  Hunan Nucien Pharmaceutical Co., Ltd. •  SCOLR Pharma •  BioCryst Pharmaceuticals, Inc.
Das engagierte Forschungs- und Analyseteam des Insight-Partners besteht aus erfahrenen Fachleuten mit fortgeschrittener statistischer Expertise und bietet verschiedene Anpassungsoptionen in der bestehenden Studie.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Peramivir Market?

Peramivir Market is expected to grow at a CAGR of 5% between 2023-2031

What are the driving factors impacting the Peramivir Market?

Several factors drive the peramivir market. Primarily, the increasing number of influenza cases, more significantly during seasonal outbreaks, forms a major driver. Since the drug is effective for severe cases of influenza, its importance in treatment cannot be denied. Moreover, with the increase in geriatric population, which tends to be more vulnerable to such severe infections, drives demand in the market even more. In addition, the development of healthcare infrastructure and the awareness of prevention and treatment of influenza are factors that are driving the market forward. As research continues to explore the potential of peramivir in broader antiviral applications, the market is expected to see continued growth in the years ahead.

What are the future trends of the Peramivir Market?

The future of the peramivir market is bright, with several emerging trends. One of the most important trends is the increasing focus on pandemic preparedness. As the world develops an increased awareness of the possibility for future pandemics, more demand for effective antiviral drugs such as peramivir will certainly be seen. Furthermore, present research and development is continuing to work on formulating and delivering peramivir in a better fashion, which may bring a better response and adherence rate in patients. In addition, the prophylactic potential of peramivir is also under scrutiny, which will create some more opportunities for growth. However, long-term trend of the peramivir market may be affected by challenges such as the emergence of drug-resistant influenza strains and development of new antiviral agents.

Which are the leading players operating in the Peramivir Market?

The leading players of the market are: Green Cross Pharma, Shionogi Co., Neopharm, Moksha8 Pharma, NT Pharma, Merck, Hikma Pharmaceuticals, Hunan Nucien Pharmaceutical Co., Ltd., SCOLR Pharma, BioCryst Pharmaceuticals, Inc.

What are the deliverable formats of the Peramivir Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Green Cross Pharma
2. Shionogi Co.
3. Neopharm
4. Moksha8 Pharma
5. NT Pharma
6. Merck
7. Hikma Pharmaceuticals
8. Hunan Nucien Pharmaceutical Co., Ltd.
9. SCOLR Pharma
10. BioCryst Pharmaceuticals, Inc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.